The automated endoscope reprocessors (AER) market involves machines that clean and disinfect flexible endoscopes to prevent infections and meet strict hospital safety standards. These systems provide a validated, automated process that reduces human error compared to manual cleaning. Market growth is driven by the rising number of endoscopic procedures for gastrointestinal and respiratory disorders, increasing focus on infection control, and stricter healthcare regulations. Hospitals, ambulatory surgical centers, and specialty clinics are key users, with North America and Europe leading adoption, while Asia-Pacific is expected to grow fastest as healthcare infrastructure expands and awareness of patient safety increases.
The global automated endoscope reprocessors (AER) market size was valued at USD 697.7 million in 2024 and is projected to grow from USD 725.6 million in 2025 to USD 1,006.4 million by 2032, exhibiting a CAGR of 4.8% during the forecast period. North America dominated the automated endoscope reprocessors (AER) market with a 49% share in 2024, driven by stringent infection control regulations, growing endoscopic procedures, and advanced healthcare infrastructure.
In September 2024, Olympus Corporation announced the launch of “Sapphire,” its first flexible endoscope sterilization facility in Melbourne, Australia. The facility was designed to deliver sterilization services to clinical institutions, highlighting the company’s commitment to advancing infection prevention practices.